Maybe I’m just being paranoid but my fear is that the market really starts to pick up steam and EVIO doesn’t take what we think should be their fair share of the testing revenue. For example competitors with deeper pockets and better operational skills take their business.

And what about when big tobacco jumps in? I saw the Altria investment this morning and probably there is more to come see the surge in related grower stocks. I’m assuming given their long history of operational success in a highly regulated environment they might already have decided how to handle testing using existing capabilities/external relationships. Just some food for thought. Over the next year we will be more certain of the relative progress, I agree we have to be patient at this point.

I just wish I had a better sense of the current testing market and competitors. If anyone has some insight on that I would appreciate it.